TIPE2 and neoplasm: To investigate the immunological mechanism underlying the anti-tumor therapeutic effect of ferroptosis treatment sensitized by TIPE2-deficient MDSCs, we checked the distribution of immune cells in the tumor tissues of WT and TIPE2−/− LLC tumor-bearing mice with IKE treatment.